The new EMA guideline on "clinical investigation of medicinal products for the treatment of Multiple Sclerosis" have now been published and will replace the current one in Oct 2015.

We are pleased and honored to see that several of the main findings from our efforts in the last 10 years have been incorporated. For more details see "Publications" on our website.